The Addario Lung Cancer Foundation is fully committed to lung cancer patients and their battle with the disease. Through collaboration and partnership with the leaders in oncology, technology, science, medicine and philanthropy, we are raising awareness, providing patient services and programs and funding research that will lead to better, more effective treatments. With our partners, our goal is to transform lung cancer into a survivable, chronically managed disease by 2023.
Merger combines more than 30 years of patient-centered expertise to "Empower Everyone, Ignore No One."
Scientists, physicians and patients collaborate to improve treatment for rare cancer.
While the living rooms take place in the ALCF's California headquarters, people around the world can tune in to the live stream, where they can participate and ask questions as if they were actually there.
When first diagnosed with lung cancer, some doctors told Bonnie J. Addario that there was nothing that they could do for her. Now, 14 years later, she has spent over a decade helping others with the disease through her Bonnie J. Addario Lung Cancer Foundation.
Vassiliki A. Papadimitrakopoulou, M.D., honored at the 19th Annual International Lung Cancer Congress.
Lung cancer registries, like the Bonnie J. Addario Lung Cancer Foundation's, can be beneficial to patients and researchers.